Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration
Clinical trial NCT04422899 · COMPLETED
Trial details
- NCT number
- NCT04422899
- Sponsor
- AiViva BioPharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-28
- Primary completion
- 2021-09-29
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.